Article

Silicone hydrogel lens backed by guarantee

Atlanta-CIBA Vision has extended its Platinum Guarantee to include its recently introduced O2OPTIX silicone hydrogel lens.

Atlanta-CIBA Vision has extended its Platinum Guarantee to include its recently introduced O2OPTIX silicone hydrogel lens.

Introduced in September 2004, O2OPTIX is a 2-week replacement lens addition to CIBA Vision's line of silicone hydrogel lenses. O2OPTIX provides the highest oxygen transmissibility of any 2-week soft lens and is designed for patients who follow a daily wear regimen with occasional overnight wear, according to the company. O2OPTIX has FDA approval for daily wear and up to 6-night extended wear.

In March 2004, CIBA Vision originally announced the Platinum Guarantee to aid practitioners when refitting Night & Day lenses for patients who currently wear soft lenses. Night & Day has FDA approval for up to 30 nights continuous wear and is ideal for patients who regularly sleep in their contact lenses. The guarantee offers refunds on up to four boxes returned by patients, as well as a $40 credit to help offset the time spent refitting. The new "Double Platinum" guarantee now includes O2OPTIX, with the same terms as the original program. The "Double Platinum" guarantee will remain in effect until the end of 2005.

"Our 'Double Platinum' guarantee provides reassurance to eyecare professionals who have been hesitant to begin upgrading to the new generation of advanced soft lens materials for their patients."

Details of the "Double Platinum" guarantee are available from CIBA Vision customer service and sales representatives.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.